I
Power Law company profile
Intarcia Therapeutics
Biotech & Life Sciences · Boston, United States · Founded 1997 Unicorn
Global footprint
Where Intarcia Therapeutics has talent and traffic
Web traffic by country
930
monthly visits
across markets
across markets
🇺🇸 United States96.8%
Patent intelligence
$49M patent portfolio · 22 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$49M
1.3% of valuation · 10.3× smaller than top peer Insulet ($502M)
22 active patent families
Where Intarcia Therapeutics innovates
Biomedical engineeringDelivery systemPeptideDrug deliveryMolecular biology
Below peer median on Legal, Strategic, Economic
Quality vs same-sector peers
Intarcia Therapeutics on the five Patsnap quality dimensions
Intarcia Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Intarcia Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Intarcia Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Intarcia Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.